This was the stock's fourth consecutive day of gains.

The US Department of Agriculture (USDA) has granted conditional approval for a new bird flu vaccine for poultry.

Zoetis was granted a conditional license for its avian influenza vaccine for use in chickens. It's a step closer to fighting ...

Zoetis' Q4 earnings met expectations, but the stock fell due to slowing growth and cautious 2025 guidance. Click here to find ...

Both of these metrics are at their most attractive levels in the company's history, making this a once-in-a-decade opportunity. Its discounted price combined with a long track record of steady growth, ...

The US Department of Agriculture last week issued a conditional license for an avian flu vaccine for use in chickens, as an ...

This was the stock's third consecutive day of gains.

Greenwich Academy's 2025 commencement speaker is Kristin Coveny Peck, the CEO of Zoetis, an animal health company.

Zoetis slightly topped analyst estimates for profitability and met those for revenue in its fourth quarter. But as investors ...

Zoetis exceeded market expectations in Q4 2024, with impressive financial performance despite challenges in specific segments ...

A New Jersey pharmaceutical company has received a “a conditional license" for its bird flu vaccine for use in chickens. An ...

What Happened? Shares of animal health company Zoetis (NYSE:ZTS) fell 10.6% in the morning session after the company reported ...